![screenshot-2024-02-08-at-5-04-43-pm.png](https://assets1.cbsnewsstatic.com/hub/i/r/2024/02/08/961c2660-6e4f-4a19-9a3e-d4eb928d8c09/thumbnail/640x360g7/ae0d0eda87594858711bf5940d4eb7f1/screenshot-2024-02-08-at-5-04-43-pm.png?v=a23cb4bdf4fa7f3cb72e5118085577f9#)
Many cancer drugs remain unproven years after accelerated approval
The FDA's accelerated approval program is meant to give patients early access to promising drugs, but a new study found most cancer drugs do not demonstrate benefits within five years.